On May 16, 2025, WEGO Cloud Innovation Park, the strategic operational hub for WEGO Group in the Yangtze River Delta region, celebrated its grand opening
Cardioplegia Delivery
WEGO Medical
For myocardial protection during open heart surgery.
WEGONODEHP
Cardioplegia Delivery
Type A requires the use of a heat exchange water tank and is currently the only product in China that has obtained registration qualifications.
Type B uses a mixture of ice and water.
Piping can be configured according to customer requirements.
Overview
WEGO Cardioplegia delivery system is a medical instrument specifically designed for open-heart surgery, primarily used to provide effective myocardial protection during the procedure.
This device ensures the precise delivery of cardioplegia solution, enabling rapid cardiac arrest and creating a clear and stable surgical field for the operation. Additionally, it helps reduce the risk of myocardial ischemic injury, protects myocardial cell viability, and promotes the recovery of cardiac function after surgery.
As a single-use product, the perfusion device offers high sterility, ease of operation, and strong safety, effectively reducing the risk of infection and enhancing both surgical quality and patient outcomes.
Specifications
Specifications
| Category | Maximum Flow Rate (L/min) | Membrane Area (m²) | Priming Volume (Excluding Tubing) (ml) | Filter Pore Size (µm) | |
| Blood-Crystalloid Type | A Type | 0.5 | 0.2 | ≤30 | 150 |
| B Type | 0.5 | — | — | — | |
| Single-Crystalloid Type | A Type | 0.5 | 0.2 | ≤30 | — |
| B Type | 0.5 | — | — | — | |
Documents
Product Details
certificate
News
Read More »
WEGO Medical Celebrates Its 37th Anniversary with Confidence and Purpose On May 8, 2025, WEGO Medical commemorated its 37th anniversary with a series of
We are excited to announce our participation in several prestigious medical exhibitions across the globe in May 2025. As a leading player in the medical
The 91st CMEF has arrived as scheduled! WEGO Group showcases cutting-edge technology, fully embodying the concept of “Leading Health Intelligence, Creating Boundless Innovation” and marking
